CBP's new import data disclosure rules, effective 2026, mean competitors see your trade data. See how this impacts strategy and what to watch next.
Editorial Team
·
Clinical trials hit $80B by 2028. See where to invest in biotech: oncology, rare diseases, AI, and WHO-aligned growth areas.
·
How will vaccine partnerships ensure equitable access by 2027? Learn key strategies for governments, pharma, and biotech to avoid future supply disparities.
·
Manual CBP reporting risks penalties by 2026. See why automated systems, like those for ACE Manifest, are now critical for trade compliance.
·
H-1B reform debates for 2026 impact tech's talent access. Learn how lobbying strategies will shift to address cap limits, lottery, and wage protections.
·
·
7 min read
Labor shortages demand action. This opinion outlines strategies to reskill 500,000 workers annually, simplify visas, and offer $10,000 relocation aid.
·
·
6 min read
NBER finds infrastructure spending returns $1.70 per dollar. See how digital investment and CBO's GDP boost factor into project success.
·
·
7 min read
How did Peachtree City's local paper combat a 2025 misinformation surge? Learn why local news trust matters & what's next for communities.
·
·
8 min read
Creators: Understand digital asset ownership, copyright, and AI challenges by 2026. Learn to protect your work and manage royalties with smart contracts.
·
·
8 min read
Georgia farms face a 2026 labor crisis. Learn how businesses are using sophisticated lobbying to push for immigration reform and avoid shutdowns.
·
·
9 min read
